Amotosalen-HCl-UVA pathogen reduction does not alter poststorage metabolism of soluble CD40 ligand, Ox40 ligand and interkeukin-27, the cytokines that generally associate with serious adverse events.

Hamzeh-Cognasse, H; Laradi, S; Osselaer, J C; Cognasse, F; Garraud, O

Hamzeh-Cognasse, H; Laradi, S; Osselaer, J C; Cognasse, F; Garraud, O.

Affiliation

Hamzeh-Cognasse H; Université de Lyon, GIMAP-EA3064, Saint Etienne, France.

Vox Sang ; 108(2): 205-7, 2015 Feb.

Article in En | MEDLINE | ID: mdl-25334045

Subject(s)

Blood Platelets/radiation effects; Blood Safety/methods; CD40 Ligand/metabolism; Furocoumarins/pharmacology; OX40 Ligand/metabolism; Ultraviolet Rays; Blood Platelets/drug effects; Blood Platelets/metabolism; Blood Safety/adverse effects; Humans; Platelet Transfusion/adverse effects

Key words

cytokine; inflammation; pathogen reduction treatment; platelet storage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Furocoumarins / Ultraviolet Rays / Blood Platelets / CD40 Ligand / OX40 Ligand / Blood Safety Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Vox Sang Year: 2015 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google